Cybersecurity Final Guidance Details System Considerations for Premarket Submissions

The frequent electronic exchange of health data through wireless, internet and networks along with the cybersecurity threats and vulnerabilities is driver for an FDA final guidance making recommendations for cybersecurity information to be submitted with premarket applications to CDRH and CBER.
Source: Drug Industry Daily